Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

379 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Second primary cancers and recurrence in patients after resection of colorectal cancer: An integrated analysis of trials by Japan Clinical Oncology Group: JCOG1702A.
Tanaka K, Ogawa G, Mizusawa J, Kadota T, Nakamura K, Shimada Y, Hamaguchi T, Fujita S, Kitano S, Inomata M, Kanemitsu Y, Fukuda H; Colorectal Cancer Study Group of Japan Clinical Oncology Group (JCOG). Tanaka K, et al. Among authors: kadota t. Jpn J Clin Oncol. 2021 Feb 8;51(2):185-191. doi: 10.1093/jjco/hyaa184. Jpn J Clin Oncol. 2021. PMID: 33157551
Factors associated with technical difficulty of endoscopic submucosal dissection for early gastric cancer that met the expanded indication criteria: post hoc analysis of a multi-institutional prospective confirmatory trial (JCOG0607).
Yano T, Hasuike N, Ono H, Boku N, Ogawa G, Kadota T, Oda I, Doyama H, Hori S, Iishi H, Takahashi A, Takizawa K, Muto M. Yano T, et al. Among authors: kadota t. Gastric Cancer. 2020 Jan;23(1):168-174. doi: 10.1007/s10120-019-00991-3. Epub 2019 Jul 18. Gastric Cancer. 2020. PMID: 31321630 Clinical Trial.
Phase III study of tri-modality combination therapy with induction docetaxel plus cisplatin and 5-fluorouracil versus definitive chemoradiotherapy for locally advanced unresectable squamous-cell carcinoma of the thoracic esophagus (JCOG1510: TRIANgLE).
Terada M, Hara H, Daiko H, Mizusawa J, Kadota T, Hori K, Ogawa H, Ogata T, Sakanaka K, Sakamoto T, Kato K, Kitagawa Y. Terada M, et al. Among authors: kadota t. Jpn J Clin Oncol. 2019 Dec 18;49(11):1055-1060. doi: 10.1093/jjco/hyz112. Jpn J Clin Oncol. 2019. PMID: 31411696 Clinical Trial.
A multicenter randomized phase III study for newly diagnosed maximally resected glioblastoma comparing carmustine wafer implantation followed by chemoradiotherapy with temozolomide with chemoradiotherapy alone; Japan Clinical Oncology Group Study JCOG1703 (MACS study).
Kadota T, Saito R, Kumabe T, Mizusawa J, Katayama H, Sumi M, Igaki H, Kinoshita M, Komori T, Ichimura K, Narita Y, Nishikawa R. Kadota T, et al. Jpn J Clin Oncol. 2019 Dec 27;49(12):1172-1175. doi: 10.1093/jjco/hyz169. Jpn J Clin Oncol. 2019. PMID: 31804699
A phase III randomized controlled trial comparing surgery plus adjuvant chemotherapy with preoperative chemoradiotherapy followed by surgery plus adjuvant chemotherapy for locally recurrent rectal cancer: Japan Clinical Oncology Group study JCOG1801 (RC-SURVIVE study).
Kadota T, Tsukada Y, Ito M, Katayama H, Mizusawa J, Nakamura N, Ito Y, Bando H, Ando M, Onaya H, Fukuda H, Kanemitsu Y. Kadota T, et al. Jpn J Clin Oncol. 2020 Aug 4;50(8):953-957. doi: 10.1093/jjco/hyaa058. Jpn J Clin Oncol. 2020. PMID: 32409830 Clinical Trial.
Protocol for a single-arm confirmatory trial of adjuvant chemoradiation for patients with high-risk rectal submucosal invasive cancer after local resection: Japan Clinical Oncology Group Study JCOG1612 (RESCUE study).
Kadota T, Ikematsu H, Sasaki T, Saito Y, Ito M, Mizutani T, Ogawa G, Shitara K, Ito Y, Kushima R, Kanemitsu Y, Muto M. Kadota T, et al. BMJ Open. 2020 Jul 14;10(7):e034947. doi: 10.1136/bmjopen-2019-034947. BMJ Open. 2020. PMID: 32665384 Free PMC article.
Diagnostic yield of conventional endoscopy with endoscopic ultrasonography for submucosal invasion of superficial esophageal squamous cell carcinoma: a post hoc analysis of multicenter prospective confirmatory study (JCOG0508).
Kadota T, Minashi K, Wakabayashi M, Yano T, Ezoe Y, Tsuchida T, Ono H, Iizuka T, Matsuura N, Oda I, Takizawa K, Katayama H, Fukuda H, Muto M. Kadota T, et al. Esophagus. 2021 Jul;18(3):604-611. doi: 10.1007/s10388-021-00815-3. Epub 2021 Jan 28. Esophagus. 2021. PMID: 33506366
Incidence and treatment outcomes of metachronous gastric cancer occurring after curative endoscopic submucosal dissection of undifferentiated-type early gastric cancer: Japan Clinical Oncology Group study-post hoc analysis of JCOG1009/1010.
Abe S, Takizawa K, Oda I, Mizusawa J, Kadota T, Ono H, Hasuike N, Yano T, Yamamoto Y, Horiuchi Y, Nagata S, Yoshikawa T, Terashima M, Muto M. Abe S, et al. Among authors: kadota t. Gastric Cancer. 2021 Sep;24(5):1123-1130. doi: 10.1007/s10120-021-01183-8. Epub 2021 Mar 31. Gastric Cancer. 2021. PMID: 33788066
379 results